Business Description
MyMD Pharmaceuticals Inc
NAICS : 541713
SIC : 2833
ISIN : US62856X1028
Share Class Description:
LTS:0A8D: Ordinary SharesDescription
MyMD Pharmaceuticals Inc is a clinical-stage pharmaceutical company committed to extending a healthy lifespan. It is developing and commercializing two therapeutic platforms. MyMD-1 is a small molecule that regulates the immunometabolic system to treat autoimmune diseases, including multiple sclerosis, diabetes, rheumatoid arthritis, and inflammatory bowel disease. It is being developed to treat age-related illnesses such as frailty and sarcopenia. Supera-1R is a synthetic derivative of CBD being developed to treat various conditions, including epilepsy, pain, and anxiety/depression, through its effects on the CB2 receptor, opioid receptors, and monoamine oxidase enzyme type B.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 100.47 | |||||
| Equity-to-Asset | 0.69 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -16.6 | |||||
| 3-Year EPS without NRI Growth Rate | -19.4 | |||||
| 3-Year FCF Growth Rate | -30.7 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.17 | |||||
| Quick Ratio | 1.17 | |||||
| Cash Ratio | 0.99 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -17.7 | |||||
| Shareholder Yield % | 1.02 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -29.85 | |||||
| ROA % | -18.04 | |||||
| ROIC % | -125.64 | |||||
| ROC (Joel Greenblatt) % | -16040.2 | |||||
| ROCE % | -87.61 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.42 | |||||
| Price-to-Tangible-Book | 2.98 | |||||
| EV-to-EBIT | -0.05 | |||||
| EV-to-EBITDA | -0.05 | |||||
| EV-to-FCF | -0.06 | |||||
| Price-to-Net-Current-Asset-Value | 28.46 | |||||
| Earnings Yield (Greenblatt) % | -2000 | |||||
| FCF Yield % | -234.99 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
MyMD Pharmaceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -5.63 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR ($) | 0 | ||
| 20-Day SMA ($) | 243.9 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range ($) | 243.9 - 243.9 | ||
| Shares Outstanding (Mil) | 2.16 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
MyMD Pharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
MyMD Pharmaceuticals Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
MyMD Pharmaceuticals Inc Frequently Asked Questions
What is MyMD Pharmaceuticals Inc(LTS:0A8D)'s stock price today?
The current price of LTS:0A8D is $243.90. The 52 week high of LTS:0A8D is $243.90 and 52 week low is $243.90.
When is next earnings date of MyMD Pharmaceuticals Inc(LTS:0A8D)?
The next earnings date of MyMD Pharmaceuticals Inc(LTS:0A8D) is 2024-05-15 Est..
Does MyMD Pharmaceuticals Inc(LTS:0A8D) pay dividends? If so, how much?
MyMD Pharmaceuticals Inc(LTS:0A8D) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers